Holen Sie sich die Stockscreener-App
7.26
4.52%
-0.26
Schlusskurs vom Vortag:
$7.52
Offen:
$7.4
24-Stunden-Volumen:
141.83K
Relative Volume:
0.14
Marktkapitalisierung:
$555.85M
Einnahmen:
$11.40B
Nettoeinkommen (Verlust:
$-95.73M
KGV:
-3.6482
EPS:
-1.99
Netto-Cashflow:
$-64.37M
1W Leistung:
-14.42%
1M Leistung:
+10.80%
6M Leistung:
-13.96%
1J Leistung:
+167.91%
1-Tages-Spanne:
$7.11
$7.58
1-Wochen-Bereich:
$6.70
$9.85
52-Wochen-Spanne:
$2.69
$12.22
Mind Medicine Inc Stock (MNMD) Company Profile
Firmenname
Mind Medicine Inc
Sektor
Branche
Telefon
212-220-6633
Adresse
ONE WORLD TRADE CENTER, NEW YORK
Vergleichen Sie MNMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| MNMD | 7.2541 | 555.85M | 11.40B | -95.73M | -64.37M | -1.99 |
| VRTX | 447.21 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 737.75 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 586.52 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.92 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.55 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-09 | Fortgesetzt | ROTH Capital | Buy |
| 2022-11-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-26 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-05-04 | Eingeleitet | ROTH Capital | Buy |
| 2021-06-28 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Mind Medicine Inc Aktie (MNMD) Neueste Nachrichten
Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Price Target at $25.38 - MarketBeat
Generalized Anxiety Disorder Market to Reach New Heights - openPR
MindMed recruits regulatory expert ahead of Phase III trials - The Pharma Letter
MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer - BioSpace
MindMed Appoints Former Karuna Executive to Lead Phase 3 Regulatory Strategy | MNMD Stock News - StockTitan
(MNMD) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025? - Insider Monkey
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpHere's What Happened - MarketBeat
Stock Traders Purchase Large Volume of Call Options on Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat
COMMODORE CAPITAL LP Acquires Shares in Mind Medicine Inc - GuruFocus.com
10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions - Yahoo Finance
Mind Medicine Mindmed Inc (MNMD-Q) QuotePress Release - The Globe and Mail
Can Canada’s psychedelic drug developers shake off the sector’s bad trip? - The Globe and Mail
MindMed (MNMD) to Present at Major Healthcare Investor Conferences in London, Florida | MNMD Stock News - StockTitan
Mind Medicine (MindMed)'s (MNMD) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Mind Medicine: No News = Good News (NASDAQ:MNMD) - Seeking Alpha
Adam Stanecki on Mind Medicine with Charles Kovess11 November 2023 - imdb
Mind Medicine Inc (MNMD) Q3 2024 Earnings Call Highlights: Strong Cash Position and Clinical ... By GuruFocus - Investing.com Canada
Mind Medicine Inc (MNMD) Q3 2024 Earnings Call Highlights: Stron - GuruFocus.com
Mind Medicine Inc (MNMD) Q3 2024 Earnings Call Highlights: Strong Cash Position and Clinical ... - Yahoo Finance
Mind Medicine's Triple-Digit Gains And The Recent CorrectionExcitement Or Anxiety On The Horizon? - RTTNews
MindMed Advances Phase 3 Trials in Mental Health - TipRanks
Certain Restricted Stock Units of Mind Medicine Inc. are subject to a Lock-Up Agreement Ending on 8-NOV-2024. - Marketscreener.com
Certain Common Stock of Mind Medicine Inc. are subject to a Lock-Up Agreement Ending on 8-NOV-2024. - Marketscreener.com
MindMed Reports Third Quarter 2024 Financial Results and Business Updates - Business Wire
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 10.1%What's Next? - MarketBeat
(MNMD) Trading Report - Stock Traders Daily
Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate (NASDAQ:MNMD) - Seeking Alpha
Mind Medicine (MindMed) (MNMD) to Release Quarterly Earnings on Thursday - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
MNMDMind Medicine (MindMed) Inc. Common Shares Latest Stock News & Market Updates - StockTitan
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update - The Globe and Mail
FDA is said to see “path forward” for ecstasy-based drug (DRUG:NASDAQ) - Seeking Alpha
MindMed announces exchange agreement with investors By Investing.com - Investing.com
Bright Minds rally ends as psychedelic stocks extend volatility - MSN
Bright Minds stock cools amid psychedelic volatility (DRUG:NASDAQ) - Seeking Alpha
(MNMD) Investment Analysis and Advice - Stock Traders Daily
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Rating Upgraded by Leerink Partnrs - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated at Leerink Partners - MarketBeat
Mind Medicine assumed with an Outperform at Leerink - Yahoo Finance
Stroke-recovery device using brain-computer interface receives FDA market authorization | WashU Medicine - WashU Medicine
Trend Tracker for (MNMD) - Stock Traders Daily
"TNT Radio" Jeff Ghaemaghamy on Mind Medicine with Charles Kovess28 January 2024 (Podcast Episode 2024)News - imdb
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
MindMed's SWOT analysis: psychedelic stock's potential in anxiety treatment - Investing.com
Marshall Wace LLP Has $15.58 Million Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
Mind Medicine's chief medical officer sells shares worth over $41,000 - Investing.com India
MindMed executive sells over $26k in company stock By Investing.com - Investing.com South Africa
Mind Medicine's chief medical officer sells shares worth over $41,000 By Investing.com - Investing.com UK
Generalized Anxiety Disorder Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, MOA, ROA by DelveInsight | Pfizer Inc., GlaxoSmithKline, Eli Lilly and Company, MindMed, VistaGen Pharma - Barchart
Finanzdaten der Mind Medicine Inc-Aktie (MNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mind Medicine Inc-Aktie (MNMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Liao Carrie | Chief Accounting Officer |
Sep 25 '24 |
Sale |
5.98 |
2,352 |
14,065 |
99,543 |
| Barrow Robert | Chief Executive Officer |
Sep 25 '24 |
Sale |
5.98 |
19,771 |
118,231 |
545,772 |
0.42%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):